[Federal Register Volume 67, Number 56 (Friday, March 22, 2002)]
[Notices]
[Page 13349]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-6994]



[[Page 13349]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Science Board to the Food and Drug Administration Advisory 
Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces a forthcoming meeting of a public 
advisory committee of the Food and Drug Administration (FDA). The 
meeting will be open to the public.
    Name of Committee: Science Board to the Food and Drug 
Administration.
    General Function of the Committee: The board shall provide advice 
primarily to the agency's Senior Science Advisor and, as needed, to the 
Commissioner and other appropriate officials on specific complex and 
technical issues as well as emerging issues within the scientific 
community in industry and academia. Additionally, the board will 
provide advice to the agency on keeping pace with technical and 
scientific evolutions in the fields of regulatory science; on 
formulating an appropriate research agenda; and on upgrading its 
scientific and research facilities to keep pace with these changes. It 
will also provide the means for critical review of agency-sponsored 
intramural and extramural scientific research programs.
    Date and Time: The meeting will be held on April 9, 2002, from 8 
a.m. to 4 p.m.
    Location: 5630 Fishers Lane, rm. 1066, Rockville, MD 20852.
    Contact: Susan Bond, Office of the Commissioner (HF-33), Food and 
Drug Administration, 5600 Fishers Lane, rm. 17-35, Rockville, MD 20857, 
301-827-6687, or e-mail [email protected], or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12603. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: Open committee discussion, 8 a.m. to 1 p.m.; open public 
hearing, 1 p.m. to 2 p.m.; open committee discussion, 2 p.m. to 4:30 
p.m. The board will hear and discuss emerging issues in antimicrobial 
resistance, process analytical technologies (followup), and 
biomaterials innovation; and discuss the external science review for 
FDA's Office of Regulatory Affairs.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by April 3, 2002. 
Oral presentations from the public will be scheduled between 
approximately 1 p.m. and 2 p.m. Time allotted for each presentation may 
be limited. Those desiring to make formal oral presentations should 
notify the contact person before April 3, 2002, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Susan Bond at least 
7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: March 15, 2002.
Bonnie Malkin,
Acting Senior Associate Commissioner for Communications and Constituent 
Relations.
[FR Doc. 02-6994 Filed 3-21-02; 8:45 am]
BILLING CODE 4160-01-S